Wnt/beta-Catenin pathway in human glioma: expression pattern and clinical/prognostic correlations
暂无分享,去创建一个
Xiaodong Jin | Yanyang Tu | Y. Tu | Xiaodong Jin | Ce Liu | Xiaoyang Sun | Jian Jiang | Xiangfei Bo | Zhengming Li | Aimiao Bian | Xiaodong Wang | Dai Liu | Zhengmei Wang | Lianshu Ding | Dai Liu | Ce Liu | Xiaoyang Sun | Jian Jiang | X. Bo | Zheng-Ming Li | Aimiao Bian | Xiaodong Wang | Zhengmei Wang | Lianshu Ding | Zhengming Li
[1] A. Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.
[2] Akira Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .
[3] M. Hung,et al. Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Hung,et al. β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression , 2000 .
[5] P. Polakis. Wnt signaling and cancer. , 2000, Genes & development.
[6] Andrew I Su,et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. , 2002, The American journal of pathology.
[7] V. Gorgoulis,et al. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. , 2002, The American journal of pathology.
[8] N. Perrimon,et al. The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.
[9] E. Wilder,et al. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. , 2002, Cancer research.
[10] N. Perrimon,et al. The promise and perils of Wnt signaling through beta-catenin. , 2002, Science.
[11] G. Evan,et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc–induced apoptosis , 2002, The Journal of cell biology.
[12] J. Behrens,et al. The Wnt signaling pathway and its role in tumor development , 2003, Journal of Cancer Research and Clinical Oncology.
[13] A. Potti,et al. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.
[14] S T Pals,et al. Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines , 2004, British Journal of Cancer.
[15] T. Kurihara,et al. Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. , 2004, Thyroid : official journal of the American Thyroid Association.
[16] C. Rubini,et al. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma. , 2005, Oncology reports.
[17] K. Arihiro,et al. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. , 2005, Oncology reports.
[18] J. Varakis,et al. ILK over‐expression in human colon cancer progression correlates with activation of β‐catenin, down‐regulation of E‐cadherin and activation of the Akt–FKHR pathway , 2006, The Journal of pathology.
[19] Yan Gao,et al. Aberrant expression of beta-catenin, Pin1 and cylin D1 in salivary adenoid cystic carcinoma: relation to tumor proliferation and metastasis. , 2006, Oncology reports.
[20] Y. Fujii,et al. Aberrant nuclear localization of β-catenin without genetic alterations in β-catenin or Axin genes in esophageal cancer , 2007, World journal of surgical oncology.
[21] Takashi Nakashima,et al. Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. , 2008, European journal of cancer.
[22] C. Lundberg,et al. Identification of proteins involved in neural progenitor cell targeting of gliomas , 2009, BMC Cancer.
[23] J. Maris,et al. Deregulated Wnt/β-catenin program in high-risk neuroblastomas without MYCN amplification , 2008, Oncogene.
[24] H. Jiang,et al. Downregulation of Wnt2 and β-catenin by siRNA suppresses malignant glioma cell growth , 2009, Cancer Gene Therapy.
[25] V. Santosh,et al. Clinical and immunohistochemical prognostic factors in adult glioblastoma patients. , 2009, Clinical neuropathology.
[26] Zhi-qiang Zhang,et al. [Significance of beta-catenin and Cyclin D1 express in glioma]. , 2009, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.
[27] R. Fimmers,et al. Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients , 2009, Clinical Cancer Research.
[28] A. Mahadevan,et al. Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas , 2009, Neurochemistry International.
[29] Lei Wang,et al. β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells , 2011, Medical oncology.